A systematic review and meta-analysis of the prevalence of toxoplasmosis in hemodialysis patients in Iran

OBJECTIVES Toxoplasmosis is a parasitic disease that occurs worldwide, with a wide range of complications in immunocompromised patients. This systematic review and meta-analysis was performed to evaluate the seroprevalence of Toxoplasma gondii among patients undergoing hemodialysis in Iran. METHODS...

Full description

Bibliographic Details
Main Authors: Masoud Foroutan, Ali Rostami, Hamidreza Majidiani, Seyed Mohammad Riahi, Sasan Khazaei, Milad Badri, Elham Yousefi
Format: Article
Language:English
Published: Korean Society of Epidemiology 2018-04-01
Series:Epidemiology and Health
Subjects:
Online Access:http://www.e-epih.org/upload/pdf/epih-40-e2018016.pdf
id doaj-a0305a7a66c54132b7b91431984bf1d4
record_format Article
spelling doaj-a0305a7a66c54132b7b91431984bf1d42020-11-25T01:34:21ZengKorean Society of Epidemiology Epidemiology and Health2092-71932018-04-014010.4178/epih.e2018016969A systematic review and meta-analysis of the prevalence of toxoplasmosis in hemodialysis patients in IranMasoud Foroutan0Ali Rostami1Hamidreza Majidiani2Seyed Mohammad Riahi3Sasan Khazaei4Milad Badri5Elham Yousefi6 Department of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran Department of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran Department of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran Department of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, IranOBJECTIVES Toxoplasmosis is a parasitic disease that occurs worldwide, with a wide range of complications in immunocompromised patients. This systematic review and meta-analysis was performed to evaluate the seroprevalence of Toxoplasma gondii among patients undergoing hemodialysis in Iran. METHODS We searched English and Persian databases for studies reporting T. gondii seroprevalence in Iranian hemodialysis patients through December 31, 2017. Inclusion and exclusion criteria were applied. RESULTS A total of 10 studies containing 1,865 participants (1,048 patients and 817 controls) met the eligibility criteria. Immunoglobulin G (IgG) antibodies against T. gondii were found in 58% (95% confidence interval [CI], 46 to 70) of hemodialysis patients and 40% (95% CI, 31 to 50) of healthy controls, while immunoglobulin M (IgM) antibodies were found in 2% (95% CI, 0 to 6) of hemodialysis patients and 0% (95% CI, 0 to 1) of healthy controls. The meta-analysis showed that hemodialysis patients were significantly more likely to be seropositive for IgG (odds ratio [OR], 2.04; 95% CI, 1.54 to 2.70; p<0.001) and IgM (OR, 2.53; 95% CI, 1.23 to 5.22; p<0.001) antibodies against T. gondii infection than healthy individuals. CONCLUSIONS The current study revealed a high prevalence of T. gondii infection in hemodialysis patients. Since hemodialysis patients are immunocompromised and T. gondii can cause serious clinical complications, we recommend that periodic screenings for T. gondii infection should be incorporated into the routine clinical care of these patients.http://www.e-epih.org/upload/pdf/epih-40-e2018016.pdfSeroprevalenceHemodialysis patientsIran
collection DOAJ
language English
format Article
sources DOAJ
author Masoud Foroutan
Ali Rostami
Hamidreza Majidiani
Seyed Mohammad Riahi
Sasan Khazaei
Milad Badri
Elham Yousefi
spellingShingle Masoud Foroutan
Ali Rostami
Hamidreza Majidiani
Seyed Mohammad Riahi
Sasan Khazaei
Milad Badri
Elham Yousefi
A systematic review and meta-analysis of the prevalence of toxoplasmosis in hemodialysis patients in Iran
Epidemiology and Health
Seroprevalence
Hemodialysis patients
Iran
author_facet Masoud Foroutan
Ali Rostami
Hamidreza Majidiani
Seyed Mohammad Riahi
Sasan Khazaei
Milad Badri
Elham Yousefi
author_sort Masoud Foroutan
title A systematic review and meta-analysis of the prevalence of toxoplasmosis in hemodialysis patients in Iran
title_short A systematic review and meta-analysis of the prevalence of toxoplasmosis in hemodialysis patients in Iran
title_full A systematic review and meta-analysis of the prevalence of toxoplasmosis in hemodialysis patients in Iran
title_fullStr A systematic review and meta-analysis of the prevalence of toxoplasmosis in hemodialysis patients in Iran
title_full_unstemmed A systematic review and meta-analysis of the prevalence of toxoplasmosis in hemodialysis patients in Iran
title_sort systematic review and meta-analysis of the prevalence of toxoplasmosis in hemodialysis patients in iran
publisher Korean Society of Epidemiology
series Epidemiology and Health
issn 2092-7193
publishDate 2018-04-01
description OBJECTIVES Toxoplasmosis is a parasitic disease that occurs worldwide, with a wide range of complications in immunocompromised patients. This systematic review and meta-analysis was performed to evaluate the seroprevalence of Toxoplasma gondii among patients undergoing hemodialysis in Iran. METHODS We searched English and Persian databases for studies reporting T. gondii seroprevalence in Iranian hemodialysis patients through December 31, 2017. Inclusion and exclusion criteria were applied. RESULTS A total of 10 studies containing 1,865 participants (1,048 patients and 817 controls) met the eligibility criteria. Immunoglobulin G (IgG) antibodies against T. gondii were found in 58% (95% confidence interval [CI], 46 to 70) of hemodialysis patients and 40% (95% CI, 31 to 50) of healthy controls, while immunoglobulin M (IgM) antibodies were found in 2% (95% CI, 0 to 6) of hemodialysis patients and 0% (95% CI, 0 to 1) of healthy controls. The meta-analysis showed that hemodialysis patients were significantly more likely to be seropositive for IgG (odds ratio [OR], 2.04; 95% CI, 1.54 to 2.70; p<0.001) and IgM (OR, 2.53; 95% CI, 1.23 to 5.22; p<0.001) antibodies against T. gondii infection than healthy individuals. CONCLUSIONS The current study revealed a high prevalence of T. gondii infection in hemodialysis patients. Since hemodialysis patients are immunocompromised and T. gondii can cause serious clinical complications, we recommend that periodic screenings for T. gondii infection should be incorporated into the routine clinical care of these patients.
topic Seroprevalence
Hemodialysis patients
Iran
url http://www.e-epih.org/upload/pdf/epih-40-e2018016.pdf
work_keys_str_mv AT masoudforoutan asystematicreviewandmetaanalysisoftheprevalenceoftoxoplasmosisinhemodialysispatientsiniran
AT alirostami asystematicreviewandmetaanalysisoftheprevalenceoftoxoplasmosisinhemodialysispatientsiniran
AT hamidrezamajidiani asystematicreviewandmetaanalysisoftheprevalenceoftoxoplasmosisinhemodialysispatientsiniran
AT seyedmohammadriahi asystematicreviewandmetaanalysisoftheprevalenceoftoxoplasmosisinhemodialysispatientsiniran
AT sasankhazaei asystematicreviewandmetaanalysisoftheprevalenceoftoxoplasmosisinhemodialysispatientsiniran
AT miladbadri asystematicreviewandmetaanalysisoftheprevalenceoftoxoplasmosisinhemodialysispatientsiniran
AT elhamyousefi asystematicreviewandmetaanalysisoftheprevalenceoftoxoplasmosisinhemodialysispatientsiniran
AT masoudforoutan systematicreviewandmetaanalysisoftheprevalenceoftoxoplasmosisinhemodialysispatientsiniran
AT alirostami systematicreviewandmetaanalysisoftheprevalenceoftoxoplasmosisinhemodialysispatientsiniran
AT hamidrezamajidiani systematicreviewandmetaanalysisoftheprevalenceoftoxoplasmosisinhemodialysispatientsiniran
AT seyedmohammadriahi systematicreviewandmetaanalysisoftheprevalenceoftoxoplasmosisinhemodialysispatientsiniran
AT sasankhazaei systematicreviewandmetaanalysisoftheprevalenceoftoxoplasmosisinhemodialysispatientsiniran
AT miladbadri systematicreviewandmetaanalysisoftheprevalenceoftoxoplasmosisinhemodialysispatientsiniran
AT elhamyousefi systematicreviewandmetaanalysisoftheprevalenceoftoxoplasmosisinhemodialysispatientsiniran
_version_ 1725072868966924288